colon – Página 5

A novel multiplexing PCR-based assay of the anaylisis of chromosome 18q status in colorectal cancer

Nadina Erill^1, Anna Colomer¹, Miquel Calvo², August Vidal^3, Ruth Román¹, Montse Verdú³, Carlos Cordón-Cardó⁴, Xavier Puig ^1,3.

¹BIOPAT, Grup Assistència, ²Statistics Department, Universitat de Barcelona, ³HISTOPAT Laboratoris, Barcelona, and ⁴Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York.

Chromosome 18q allelic loss has been reported to have prognostic significance in stage II colorectal carcinoma. We have […]

aguardiola 2005-07-23T17:07:51+00:00

A novel logistic model based on clinicopathological features predicts microsatellite instability in colorectal carcinomas

Anna Colomer^1, Nadina Erill¹, August Vidal², Miquel Calvo³, Ruth Román^1, Montse Verdú², Carlos Cordon-Cardo⁴, Xavier Puig ^1,2.

¹BIOPAT, Grup Assistència, Barcelona; ²HISTOPAT Laboratoris, Barcelona; ³Statistics Department of the Universitat de Barcelona, Barcelona and ⁴Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York.

High-frequency microsatellite instability has been reported to be […]

aguardiola 2005-07-23T17:06:28+00:00

BRAF mutations in colorectal cancer are linked to loss of hMLH1 expression and proximal location, while independent of K-RAS activation

Anna Colomer¹, Nadina Erill ¹, August Vidal², Ruth Román¹, Montse Verdú², Carlos Cordon-Cardo³, Xavier Puig ^1,2.

¹BIOPAT, Grup Assistència, Barcelona, Spain; ²HISTOPAT Laboratoris, Barcelona, Spain; ³Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York.

The RAF gene family encodes RAS-regulated kinases that mediate cellular responses to growth signals. […]

aguardiola 2004-07-23T17:02:21+00:00

Microsatellite analysis of chromosome 18 in colorectal cancer

Erill N¹, Colomer A¹, Calvo M³, Vidal A², Román R¹, Verdú M², Cordon-Cardo C⁴, Puig X^1,2.

¹BIOPAT, ²HISTOPAT Laboratoris, ³Statistics Dept. of the Universitat de Barcelona, Spain; and ⁴Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York.

Chromosome 18q allelic loss (c18q LOH) seems to have prognostic significance in stage II colorectal carcinoma. In our laboratory […]

aguardiola 2003-07-23T17:00:47+00:00

Lack of p53 nuclear immunostaining is not indicative of absence of TP53 gene mutations in colorectal adenocarcinomas

Anna Colomer,¹ Nadina Erill,¹ Montse Verdú,² Ruth Roman,¹ August Vidal,^1,2 Carlos Cordon-Cardo,^1,3 Xavier Puig^1,2

¹BIOPAT, Grup Assistència, Barcelona; ²HISTOPAT Laboratoris, Barcelona; and ³Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York.

Multiple studies using primary tumors have reported that alterations in p53 expression and detection of TP53 mutations are associated with clinical aggressiveness and poor response […]

aguardiola 2003-07-23T16:51:27+00:00

Previous 3 4 5 6 Next